| From The Editor's Desk |
broadening our vision.
- Corboy, John, MD, FAAN. Pages: 89-90
|
| The Nerve! Readers Speak |
can cerebral microbleeds cause an acute stroke syndrome?.
- Kalamangalam, Giridhar, MD, DPhil. Pages: 91-93
|
| Clinical and Ethical Challenges |
diagnosis and treatment of somatoform disorders.
- Smith, Jonathan, Jozefowicz, Ralph. Pages: 94-102
>
Show/Hide Summary
Summary: Many patients with somatoform disorders present to the neurology clinic, often after extensive evaluation that has left the patient and multiple other physicians frustrated. Knowledge of the typical characteristics of particular disorders enables the clinician to arrive at a positive diagnosis and facilitate referral to appropriate services. Using a series of representative cases, we review the DSM-IV-TR somatoform disorders most likely to present to the practicing neurologist, highlighting the epidemiologic features, typical presentations, and possible therapeutic approaches to each condition.(C)2012AAN Enterprises, Inc.
|
approach to the elderly patient with gait disturbance.
- Marshall, Frederick. Pages: 103-111
>
Show/Hide Summary
Summary: The prevalence of gait disturbances and falls increases dramatically with age, but these problems are not universal in the elderly. They should trigger a systematic search for underlying disease states, many of which can be treated medically or surgically, or significantly ameliorated through provision of physical therapy focused on gait training and aids to ambulation, removal of safety hazards in the environment, and the elimination of polypharmacy. While cardiovascular, orthopedic, and rheumatologic diseases account for the majority of gait disturbances in the elderly, the aim here is to outline an approach to the diagnosis and treatment of a broad array of neurologic conditions causing gait disturbance in the elderly.(C)2012AAN Enterprises, Inc.
|
smoking cessation for the neurologic patient.
- Tavee, Jinny. Pages: 112-121
>
Show/Hide Summary
Summary: Given the vast health and socioeconomic effects of tobacco use, smoking cessation is no longer a topic reserved for the primary care physician. As a modifiable risk factor that can lead to stroke, dementia, multiple sclerosis, and other neurologic diseases, cigarette smoking should be addressed by all health care providers, including neurologists. Counseling, nicotine replacement therapies, and other medications are the mainstays of treatment. However, even brief advice from a health care professional at the end of a routine office visit can increase a patient's chances of quitting. Armed with a better understanding of smoking's effect on neurologic disease and available resources, such as toll-free quit lines and Web-based interventions, neurologists can help their patients who smoke take the first step to successful cessation.(C)2012AAN Enterprises, Inc.
|
medical decisions are not just about the facts: what a life-threatening virus can teach us about empathy, psychology, and the practice of neurology.
- Kachuck, Norman. Pages: 122-128
>
Show/Hide Summary
Summary: Getting the facts about risk and benefit is a critical part of medical decision-making. But when doctors and patients disagree on what is reasonable risk, it takes more than a grasp of the data to establish the way forward. Our competence as physician-scientists relies on our ability to master the mechanics and information flow of our specialty. But we physicians, curious amalgams of scientists, scholars, researchers, and healers, should be aware of how we respond to the uniqueness of each of our physician-patient relationships, and be willing to explore ways in which the psychological and interpersonal dynamics influence the ethical, medically correct choices we pursue in them.(C)2012AAN Enterprises, Inc.
|
| Five New Things |
neuro-ophthalmology: five new things.
- Cornblath, Wayne. Pages: 129-133
>
Show/Hide Summary
Summary: The field of neuro-ophthalmology is broad and interacts with other disciplines in neurology and ophthalmology along with neurosurgery, neuroradiology, rheumatology, and infectious disease. A number of interesting advances in diagnostic criteria, monitoring ability, and disease etiology have occurred in the last year that will improve our ability to take care of patients.(C)2012AAN Enterprises, Inc.
|
| Eye on Practice |
an analysis of aan's evidence-based guideline for ivig use in neurologic disorders: provider impact and payer perspectives.
- Satya-Murti, Saty, MD, FAAN, Shepard, Katie, Kaufman, Joel, MD, FAAN. Pages: 134-138
>
Show/Hide Summary
Summary: Health insurers look for reliable, published evidence such as evidence-based guidelines put forth by medical specialty societies to craft their coverage policies. These guidelines generate both beneficial and controversial consequences on policies. Coverage policies aim to address the most typical clinical presentations. The American Academy of Neurology guideline for IV immunoglobulin strengthens the case for coverage when it is used to treat Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. The guideline is less likely to strengthen coverage for several other diagnoses with lower levels of evidence. The responsibility to clarify specific situations when patient need falls outside of what is considered to be routine evaluation or treatment rests heavily on the physician. Advice on appealing an unfavorable coverage decision is also provided to the reader.(C)2012AAN Enterprises, Inc.
|
the aan's role in the development of health insurer coverage policy.
- Satya-Murti, Saty, MD, FAAN, Shepard, Katie. Pages: 139-145
>
Show/Hide Summary
Summary: Scientific, evidence-based clinical practice guidelines (CPGs) differ from coverage/policy statements. The latter incorporate values and priorities and translate evidence into human benefit. They assist provider and payer decisions, and abide by extant laws and regulations. Payers have set internal processes for balancing and integrating the intent of CPGs into their coverage/payment policies. Recently, however, their efforts to reach out to respected medical specialty societies for input are increasing. In response, the American Academy of Neurology (AAN) has taken the following steps: 1) it is reacting to, and providing input to, payer requests for policy reviews; 2) it is taking a proactive approach by developing AAN guideline companion documents that describe potential provider impacts and policy implications; and 3) it is commencing an initiative to write its own template policies. This new involvement has met with initial positive outcomes. The AAN will continue to expand efforts to fulfill a growing need in this area.(C)2012AAN Enterprises, Inc.
|
is intraoperative neuromonitoring a good idea in my practice?.
- Katharina Ritzl, Eva, MD, FRCP. Pages: 146-150
>
Show/Hide Summary
Summary: Intraoperative neuromonitoring (IONM) is a growing field within neurology. IONM uses a variety of neurophysiologic modalities to detect signs of potential injury to neural structures while a patient is undergoing surgery. An early warning to the surgeon about signal changes may prevent permanent neurologic disability. Since all monitoring is done in real time, the work pace is fast. The operating room environment poses additional challenges for signal acquisition and interpretation. Specific training in the field is becoming increasingly available. Several practice models exist and IONM can be performed in an academic or a private practice setting. A career in intraoperative neuromonitoring can offer lots of opportunities, a high degree of job satisfaction, and flexibility to those choosing to enter the field.(C)2012AAN Enterprises, Inc.
|
| Current Controversies |
diagnostic tests for alzheimer disease: fdg-pet imaging is a player in search of a role.
- Knopman, David. Pages: 151-153
|
diagnostic tests for alzheimer disease: judicious use can be helpful in clinical practice.
- Dickerson, Bradford. Pages: 154-157
|
| Cases |
cauda equina syndrome secondary to intravascular lymphoma.
- Abuzinadah, Ahmad, Almalik, Yaser, Shabani-Rad, Meer-Taher, MD, FRCPS, Ho, Chester, George, David, Alant, Jacob, Zochodne, Douglas, MD, FRCP. Pages: 158-161
|
early sign of hemodynamic insufficiency in the mca watershed territories: just the (finger)tip of the iceberg?.
- Zizlsperger, Leopold, Ernemann, Ulrike, Erharhaghen, Jite, Melms, Arthur, Haarmeier, Thomas. Pages: 162-164
|
asymptomatic swollen optic discs and ct scan.
- Bidot, Samuel, Lamirel, Cedric. Pages: 165-166
|
aneurysm of the internal carotid artery with bone arrosion and extradural compression of the optic nerve.
- Barbe, Michael, Liebig, Thomas, Fink, Gereon, Meister, Ingo, Dorn, Franziska. Pages: 167-168
|